Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-175-30
Published November 26, 2025 · Recall initiated: October 10, 2025
Summary
FDA records drug Class III recall D-0156-2026, published November 26, 2025 and initiated October 10, 2025. Recalling firm: Alembic Pharmaceuticals Limited; Status: Ongoing; Reported quantity: 4,884 30-count bottles; Lot: Lot # 2405006633, Exp Date: 03/31/2026. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email if FESOTERODINE FUMARATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FESOTERODINE FUMARATE
- Manufacturer
- Alembic Pharmaceuticals Limited
- Distributor
- Nationwide in the USA.
- UPC
- 0362332176304
- Lot
- Lot # 2405006633, Exp Date: 03/31/2026
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAFesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: AlembicJanuary 14, 2026
- FDAKlarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug,November 26, 2025
- FDANIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers UrbanNovember 26, 2025
- FDAMultichem ID-B. Model/Catalog Number: SR103B Intended for use as an unassayed positive qualitative qualityNovember 19, 2025
- FDAApplied Medical Technology, Inc., NutraGlide, 6 F- 8 F x 90 Nasal Feeding Tube with Stylet and ENfit, REFNovember 19, 2025
- FDAAffinity NT Oxygenator, Oxygenator with Balance Biosurface and Uncoated Cardiotomy/Venous Reservoir, ProductNovember 19, 2025
Questions about this recall
Was Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-175-30 recalled?
Yes. FDA published recall D-0156-2026 on November 26, 2025. Reported hazard: Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FESOTERODINE FUMARATE. UPC: 0362332176304.